Emma, it may be that not all of the information is available to you - Steve was a member here for such a short time so there were certain things we never asked him. I hope some of these points will help clarify your thinking:-
- very young men diagnosed with PCa often seem to have a particularly aggressive form which does not respond to any treatment
- spread to the skull seems to have a particularly swift outcome
- he never had a biopsy so there is no way of knowing what type of prostate cancer he had - it has behaved though like one of the rarer types which are so hard to treat
- at the point that Steve was given 'early' chemo, that was still a newish approach and only just out of the trial stage so the onco was apparently on the ball and willing to try things
- it may seem a bit weird that he sent Steve away for 3 months with a rising PSA but PSA rises after chemo are quite common as the cancer cells are objecting to the attack
- Steve had already been told at that point that he was terminally ill so perhaps they had a discussion about introducing abiraterone or enzalutimide that you are not aware of, or perhaps by the time the onco realised this wasn't a normal PSA chemo thing, it was too late
- if it was one of the rare types that do not respond to HT, abiraterone and enza would perhaps have been ineffective
- why was he struggling to walk towards the end? Was that because of lymphodema, spinal cord compression, balance issues (brain mets?) or because he was so weakened / loss of appetite or similar?
I suspect that he was diagnosed so late and with such an aggressive strain, that nothing would have kept him here for more than a few weeks. Data on enza and abiraterone is not great for men diagnosed very late - an estimate of an extra 6 weeks I think. But you need peace of mind and so if the onco is willing to see you, that is probably a very sensible thing to do. If you get the opportunity, you could ask:
- in hindsight, why does he think it was so swift
- does he think that Steve may have had a rare type since it behaved so atypically, and did that influence his treatment decisions
- what was the actual cause of death - you don't usually die from PCa but from either the side effects of treatment, infection or the failure of major organs
I hope that you do find a way to get some of these answers. I tried to see my father-in-law's oncologist after he died because he did not follow a normal pattern at all. However, the onco consistently refused to meet with me and in the end, i had to be satisfied with my husband's onco looking at the stats for me simply in relation to 'was there anything unusual or significant that could impact on his son's outcomes' ... a bit of a round-the-houses way of doing things, and didn't get me all the answers I wanted, but enough to be able to accept I wasn't going to get anything else out of them and needed to move on.
One last thought - there are different kinds of moving on. It is important that you find a way to move on from 'if this happened he might still be here' 'if that happened he might have had longer' because in all honesty, I think they will tell you that Steve did well to be around for 9 months. That is not the same as moving on as in 'forget him and get better and start acting like it never happened and you are really, really happy.' Anyone who expects you to do #2 is an insensitive fool but everyone who cares for you would probably wish for you to get to #1 soon, since that is where peace is to be found.